Atomera(ATOM)2025-05-06 20:45Financial Performance - The company reported a net loss of $5.2 million, or $0.17 per share, for Q1 2025, compared to a net loss of $4.8 million, or $0.19 per share, in Q1 2024[4] - Adjusted EBITDA for Q1 2025 was a loss of $4.4 million, compared to a loss of $4.0 million in Q1 2024[4] - Total revenue for Q1 2025 was $4,000, compared to $18,000 in Q1 2024, reflecting a significant decrease[16] - Operating expenses increased to $5.5 million in Q1 2025 from $5.0 million in Q1 2024, primarily driven by R&D and administrative costs[16] - The accumulated deficit as of March 31, 2025, was $226.7 million, up from $221.5 million at the end of 2024[14] Cash Position - Cash and cash equivalents decreased to $24.1 million as of March 31, 2025, down from $26.8 million as of December 31, 2024[5] - The total number of shares outstanding was 30.7 million as of March 31, 2025[6] Strategic Initiatives - The company signed a strategic marketing agreement with a leading chip fabrication equipment vendor to enhance deal execution and drive license revenues[3] - The company expanded engagements with STMicroelectronics and RF SOI customers to new applications, indicating growth opportunities[8] - The company built its first MST-enabled GaN devices at Sandia and began electrical testing, showcasing advancements in technology[8]